Particle News: Latest Most favoured nation news

Pfizer Agrees to MFN Medicaid Pricing, Joins ‘TrumpRx’ in White House Deal With 3-Year Tariff Reprieve

Discounts plus a direct-sale portal are slated for 2026, with unclear effects on Medicare or commercially insured patients.

White House Secures Pfizer Deal on Drug Prices With TrumpRx Discounts and $70 Billion U.S. Investment

AGOA Set to Lapse as African Officials Tout Short U.S. Extension and Factories Prepare Cuts

Bristol Myers Sets U.K. Price for New Schizophrenia Drug Equal to U.S., Threatens to Pull Product

India-to-U.S. Air Cargo Plunges After U.S. Tariffs Double

U.S. and EU Finalize Tariff Deal Capping Most Duties at 15%

U.S. and EU Publish Trade Framework Capping Many Tariffs at 15% as Washington Expands 50% Metals Duties

Trump Gives Pharma Until September 29 to Match Lowest Global Drug Prices

Trump Gives Pharma CEOs 60 Days to Adopt Most-Favored-Nation Drug Pricing

Swiss State Secretary Highlights Red Tape Reform as Key to $100 Billion EFTA-India Investment

Trump's Executive Order Enacts Global Benchmark for U.S. Drug Prices

Rep. Ro Khanna Files Legislation to Codify Trump’s Drug Pricing Executive Order

Indian Pharma Stocks Decline as Trump Announces Major Drug Price Cuts